Leflunomide CAS 75706-12-6 Health Care High Quality

Product Details
Customization: Available
Transport Package: Drum
Specification: 99%
Still deciding? Get samples of US$ 50/Piece
Request Sample
Diamond Member Since 2017

Suppliers with verified business licenses

Audited Supplier

Audited by an independent third-party inspection agency

Management System Certification
ISO 9001
Export Year
2016-08-01
Terms of Payment
LC, T/T, D/P, PayPal, Western Union, Small-amount payment, Money Gram, cash
  • Leflunomide CAS 75706-12-6 Health Care High Quality
  • Leflunomide CAS 75706-12-6 Health Care High Quality
  • Leflunomide CAS 75706-12-6 Health Care High Quality
  • Leflunomide CAS 75706-12-6 Health Care High Quality
  • Leflunomide CAS 75706-12-6 Health Care High Quality
  • Leflunomide CAS 75706-12-6 Health Care High Quality
Find Similar Products
  • Overview
  • Product Description
  • Detailed Photos
Overview

Basic Info.

Model NO.
75706-12-6
Origin
China
Production Capacity
10000kg/Month

Product Description

Product Description

 

Leflunomide, marketed under the brand name Arava, is a disease-modifying antirheumatic drug (DMARD) used to treat the symptoms of rheumatoid arthritis (RA). It is also used for the prevention of acute and chronic rejection in recipients of solid organ transplants. Leflunomide is a pyrimidine synthesis inhibitor that works by inhibiting the enzyme dihydroorotate dehydrogenase (DHODH), which is involved in the de novo synthesis of pyrimidines. This inhibition affects the proliferation of activated lymphocytes, which are crucial in the autoimmune response seen in conditions like RA.

The drug is well absorbed, with peak plasma concentrations appearing 6-12 hours after dosing. It has a volume of distribution of approximately 0.13 L/kg and is highly protein-bound (>99.3%). Leflunomide is metabolized primarily in the liver and has a half-life of about two weeks. The active metabolite is eliminated through renal excretion and biliary excretion.

Leflunomide is typically initiated with a loading dose of 100 mg per day for three days, followed by a maintenance dose of 20 mg per day. However, if the drug is not well tolerated, the maintenance dose may be decreased to 10 mg per day. It is important to monitor blood pressure, blood cells, and liver function regularly during treatment with leflunomide.

Common side effects of leflunomide may include nausea, diarrhea, stomach pain, headache, abnormal liver function tests, thinning hair, back pain, weakness, rash, and high blood pressure. More serious side effects can occur, such as signs of infection, liver problems, and severe skin reactions. Leflunomide can also cause severe or fatal liver damage, and its use is contraindicated in patients with severe liver disease or those who are pregnant, as it may harm an unborn baby.


 

Detailed Photos
Leflunomide CAS 75706-12-6 Health Care High Quality

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier